EcoDrugPlus

Dihydropyrimidine Dehydrogenase

Ensembl ID : ENSFCAG00000039421
Gene Symbol: DPYD
5 Cross references
228 Possible Orthologues:

Dipeptidyl Peptidase 4

Ensembl ID : ENSFCAG00000004460
Gene Symbol: DPP4
5 Cross references
286 Possible Orthologues:

Discoidin Domain Receptor Tyrosine Kinase 2

Ensembl ID : ENSFCAG00000009163
Gene Symbol: DDR2
5 Cross references
264 Possible Orthologues:

Dopamine Receptor D1

Ensembl ID : ENSFCAG00000000764
Gene Symbol: DRD1
5 Cross references
262 Possible Orthologues:

Dopamine Receptor D2

Ensembl ID : ENSFCAG00000008293
Gene Symbol: DRD2
5 Cross references
222 Possible Orthologues:

Dopamine Receptor D3

Ensembl ID : ENSFCAG00000009553
Gene Symbol: DRD3
5 Cross references
209 Possible Orthologues:

Dopamine Receptor D4

Ensembl ID : ENSFCAG00000042124
Gene Symbol: DRD4
4 Cross references
245 Possible Orthologues:

Dopamine Receptor D5

Ensembl ID : ENSFCAG00000011315
Gene Symbol: DRD5
5 Cross references
164 Possible Orthologues:

Ectonucleotide Pyrophosphatase/phosphodiesterase 2

Ensembl ID : ENSFCAG00000010937
Gene Symbol: ENPP2
5 Cross references
227 Possible Orthologues:

Egl-9 Family Hypoxia Inducible Factor 1

Ensembl ID : ENSFCAG00000023997
Gene Symbol: EGLN1
5 Cross references
239 Possible Orthologues:

Egl-9 Family Hypoxia Inducible Factor 2

Ensembl ID : ENSFCAG00000024463
Gene Symbol: EGLN2
5 Cross references
194 Possible Orthologues:

Egl-9 Family Hypoxia Inducible Factor 3

Ensembl ID : ENSFCAG00000040826
Gene Symbol: EGLN3
5 Cross references
208 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).